✦ LIBER ✦

799 Randomized trial of docetaxel plus clsplatin (DC) versus etoposide plus cisplatin (EC) in locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by H.S. Park; S.J. Lee; J.H. Kim; M.J. Ahn; J.A. Lee; C.Y. Yim; C.S. Kim; S. Mun; Y.S. Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of gemcitabine

✍ Kim, Jee Hyun; Kim, Si Young; Jung, Kyung Hae; Park, Keunchil; Suh, Cheol Won; L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

1BA Phase III study of pemetrexed plus c

✍ C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Docetaxel plus cisplatin versus docetaxe

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Etoposide versus etoposide plus high-dos

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Phase III randomized trial of docetaxel

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 494 KB

A multicenter phase II study of the effi

✍ James C.M. Ho; E.H. Tan; S.S. Leong; C.H. Wang; Y. Sun; R. Li; M.I.A. Wahid; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB